Abstract
The results of treatment of glomerulonephritis (GN) in childhood with oral corticosteroids, immunosuppressive drugs, anticoagulants and the newer regimens of pulsed, high-dose intravenous methylprednisolone and plasma exchange are reviewed and compared with the natural history of the untreated condition. Poststreptococcal GN and the nephritis of Schönlein-Henoch purpura need no specific treatment unless extensive glomerular crescents are present. The progression of mesangiocapillary GN can probably be slowed or even reversed with long-term, alternate-day steroid therapy. As in adults, recovery of renal function in GN due to antibody to glomerular basement membrane can be achieved in some patients using plasma exchange, but only those in whom some renal function is still present when treatment is started. In rapidly progressive (extracapillary) GN with crescents, “traditional” therapy with oral steroids, immunosuppressive drugs and anticoagulants reduces renal mortality from 85%–90% to about 50%, while pulsed methylprednisolone and plasma exchange improve the outcome further, mortality falling to about 25%. It is recommended that children with crescentic GN and deteriorating function be treated initially with pulsed methylprednisolone, followed by plasma exchange in those who fail to respond or who deteriorate following temporary response to pulse therapy. Treatment must be given early in the course of the illness if good results are to be obtained.
Similar content being viewed by others
References
Heaf JG, Jorgensen F, Nielsen LP (1983) Treatment and prognosis of extracapillary glomerulonephritis. Nephron 35:217–224
Sieberth HG, Maurin N (1983) The therapy of rapidly progressive glomerulonephritis. Klin Wochenschr 61: 1001–1010
Cameron JS (1984) The treatment of rapidly progressive crescentic glomerulonephritis and of Goodpasture's syndrome. In: Suki WN, Massry SG (eds) Therapy of renal diseases and related disorders. Nijhoff, Dordrecht, pp 209–219
Perlman LV, Herdman RC, Kleinman H, Vernier RL (1965) Poststreptococcal glomerulonephritis: a ten year follow-up of an epidemic. JAMA 194:63–70
Potter EV, Lipschultz SA, Abidh S, Poon-King T, Earle DP (1982) Twelve to seventeen-year follow-up of patients with poststreptococcal glomerulonephritis in Trinidad. N Engl J Med 307:725–729
Schacht RG, Gluck MC, Gallo G, Baldwin DS (1976) Progression to uremia after remission of acute poststreptococcal glomerulonephritis. N Engl J Med 295:977–981
Baldwin DS (1977) Poststreptococcal glomerulonephritis: a progressive disease? Am J Med 62:1–11
Edelmann CM Jr, Greifer I, Barnett HL (1964) The nature of kidney disease in children who fail to recover from apparent acute glomerulonephritis. J Pediatr 64:879–887
Kurtzman NA (1978) Does acute poststreptococcal glomerulonephritis lead to chronic renal disease? N Engl J Med 298:795–796
Meadow SR, Glasgow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258
Habib R, Levy M (1972) Les nephropathies du purpura rhumatoïde chez l'enfant. Arch Fr Pediatr 29:305–324
Koskimies O, Rapola J, Savilahti E, Vilska J (1974) Renal involvement in Schönlein-Henoch purpura. Acta Paediatr Scand 63:357–363
Haycock GB, Cameron JS (1987) Schönlein-Henoch purpura. In: Bayless TM, Brain MC, Cherniack RM (eds) Current therapy in internal medicine, Becker, Toronto, pp 1094–1096
Niaudet P, Levy M (1983) Glomérulonéphrites à croissants diffus. In: Royer P, Habib R, Mathieu H, Broyer M (eds) Néphrologie pédiatrique, 3rd edn. Flammarion, Paris, pp 381–394
Cole BR, Brocklebank JT, Kienstra RA, Kissane JM, Robson AM (1976) ‘Pulse’ methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr 88: 307–314
Habib R, Kleinknecht C, Gubler MC, Levy M (1973) Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol 1:194–214
Cameron JS (1979) Mesangiocapillary glomerulonephritis. In: Strauss J (ed) The nephrotic syndrome. Pediatric Nephrology, vol 5, Garland Press, New York, pp 153–184
Kincaid-Smith P (1972) The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function. Med J Aust 2:587–592
Chapman SJ, Cameron JS, Chantler C, Turner D (1980) Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation. Arch Dis Child 55:446–451
Brown CB, Wilson D, Turner D, Cameron JS, Ogg CS, Chantler C, Gill D (1974) Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet II:1166–1172
Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27:436–441
McAdams AJ, McEnery PT, West CD (1975) Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long term alternate day prednisone therapy. J Pediatr 86:23–31
McEnery PT, McAdams AJ, West CD (1980) Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy. Clion Nephrol 13: 117–124
Warady BA, Guggenheim SJ, Sedman A, Lunn GM (1985) Prednisone therapy of membranoproliferative glomerulonephritis in children. J Pediatr 107:702–707
A Report of the International Study of Kidney Disease in Children (1982) Alternate day steroid therapy in membranoproliferative glomerulonephritis: a randomized controlled clinical trial. Kidney Int 21: 150
Mota-Hernandez F, Gordillo-Paniagua G, Muñoz-Arizpe R, Lopez-Arriaga JA, Barboza-Madueño (1985) Prednisone versus placebo in membranoproliferative glomerulonephritis: long term clinical correlations. Int J Pediatr Nephrol 6:25–28
Proskey AJ, Weatherbee L, Easterling RE, Greene JA, Weller JM (1970) Goodpasture's syndrome. A report of five cases and review of the literature. Am J Med 48: 162–173
Wilson CB, Dixon FJ (1973) Antiglomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3:74–89
Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH (1984) Goodpasture's syndrome. A clinicopathological entity. Am J Med 34:424–444
Lockwood CM, Pearson TA, Rees AJ, Evans DJ, Peters DK, Wilson CB (1976) Immunosuppression and plasmaexchange in the treatment of Goodpasture's syndrome. Lancet 1:711–715
Anand SK, Landing BH, Heuser ET, Olson DL, Grushkin CM, Lieberman E (1978) Changes in glomerular basement antigen(s) with age. J Pediatr 92:952–953
O'Connell EJ, Dower JC, Burke EC, Brown AL Jr, McCaughey WTE (1964) Pulmonary haemorrhage-glomerulonephritis syndrome. Am J Dis Child 108:302–308
Ozsoylu S, Hicsonmez G, Berkel I, Say B, Tinaztepe B (1976) Goodpasture's syndrome (pulmonary haemosiderosis with nephritis). Clin Pediatr (Phila) 15:358–360
Siegler RL, Bond RE, Morris AH (1980) Treatment of Goodpasture's syndrome with plasma exchange and immunosuppression. Clin Pediatr (Phila) 19:488–491
Levin M, Rigden SPA, Pincott JR, Lockwood CM, Barratt TM, Dillon MJ (1983) Goodpasture's syndrome: treatment with plasmapheresis, immunosuppression and anticoagulation. Arch Dis Child 58:697–702
Whitworth JA, Morel-Maroger L, Mignon F, Richet G (1976) The significance of extracapillary proliferation: clinicopathological review of 60 patients. Nephron 16: 1–19
Bolton WK, Couser WG (1979) Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am J Med 66:495–502
Neild GH, Cameron JS, Ogg CS, Turner DR, Williams DG, Brown CB, Chantler C, Hicks J (1983) Rapidly progressive glomerulonephritis with extensive glomerular crescent formation. Q J Med 52:395–416
Schreiner GE, Rakowski TA, Argy WD Jr, Marc-Aurele J, Maher JF, Bauer H (1972) Natural history of oliguric glomerulonephritis. In: Kincaid-Smith P, Mathew TH, Becker EL (eds) Glomerulonephritis: morphology, natural history and treatment. Wiley, New York, p 711
Davis CA, McEnery PT, Maby S, McAdams AJ, West CD (1978) Observations of the evolution of rapidly progressive glomerulonephritis. Clin Nephrol 9:91–101
Roy S III, Murphy WM, Arant BS (1981) Poststreptococcal crescentic glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr 98:403–410
Cunningham RJ III, Gilfoil M, Cavallo T, Brouhard B, Travis L, Berger M, Petrusick T (1980) Rapidly progressive glomerulonephritis in children: a report of thirteen cases and a review of the literature. Pediatr Res 14:128–132
Cameron JS, Gill D, Turner DR, Chantler C, Ogg CS, Vosnides G, Williams DG (1975) Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet II:923–925
Savage JM, Postlethwaite RJ, Lendon M, Houston IB, Evans DI (1982) Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function. Int I Pediatr Nephrol 3:167–174
Robson AM, Cole BR, Kienstra RA, Kissane JM, Alkjaersig N, Fletcher AP (1977) Severe glomerulonephritis complicated by coagulopathy: treatment with anticoagulant and immunosuppressive drugs. J Pediatr 90:881–892
Srivastrava RN, Choudry VP (1980) Rapidly progressive (crescentic) glomerulonephritis. Int J Pediatr Nephrol 1:94–96
Bell PRF, Briggs JD, Calman KC, Paton AM, Wood RFM, MacPherson SG, Kyle K (1971) Reversal of acute clinical and experimental organ rejection using large doses of intravenous methylprednisolone. Lancet I:876–880
Robson AM, Rose GM, Cole BR, Ingelfinger JR (1981) The treatment of severe glomerulopathies in children with intravenous methylprednisolone ‘pulses’. Proceedings of the 8th International Congress on Nephrology, Athens S-6 Karger, Basel: 305–311
Ferraris JR, Gallo GE, Ramirez J, Iotti R, Gianantonio C (1983) ‘Pulse’ methylprednisolone therapy in the treatment of acute crescentic glomerulonephritis. Nephron 34:207–208
O'Neill WM Jr, Etheridge WB, Bloomer HA (1979) High dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritis. Arch Intern Med 139:514–518
Oredugba O, Mazumdar DC, Meyer JS, Lubowitz H (1980) Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis. Ann Intern Med 92:504–506
Bruns FJ, Fraley DS, Adler S, Segel DP (1980) Megadose methylprednisolone versus plasmapheresis in treatment of rapidly progressive glomerulonephritis. Kidney Int 19:121
Stevens ME, McConnell M, Bone JM (1982) Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis. Proc Eur Dial Transplant Assoc 19:724–731
Bolton WK, Innes DJ Jr, Sturgill BC, Kaiser DL (1987) T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int 32:869–876
Verrier Jones J, Cumming RH, Bucknell RC, Asplin CM, Fraser ID, Bothamley J, Davis P, Hamblin TJ (1976) Plasmapheresis in the management of acute systemic lupus erythematosus. Lancet I:709–711
Lockwood CM, Pinching A, Sweny P, Rees AJ, Pussell B, Uff I, Peters DK (1977) Plasma exchange and immunosuppression in the treatment of fulminating immune-complex glomerulonephritis. Lancet I:63–67
Becker GJ, d'Apice AJF, Walker RG, Kincaid-Smith P (1977) Plasmapheresis in the treatment of glomerulonephritis. Med J Aust 2:693–696
McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan Y-L, Clarkson AR (1979) Plasmapheresis in glomerulonephritis. Clin Nephrol 12:97–108
Harmer D, Finn R, Goldsmith HJ, Bone JM, Forbes AW (1979) Plasmapheresis in fulminating crescentic nephritis. Lancet I:679
Rifle D, Chalopin JM, Zech P, Deteix P, Ducret F, Vialtel P, Cordonnier D (1980) Treatment of idiopathic acute crescentic glomerulonephritis by immunosuppression and plasma-exchanges. A prospective randomised study. Proc Eur Dial Transplant Assoc 18:493–502
Kauffmann RH, Houwert DA (1981) Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating immune complexes. Clin Nephrol 16:155–160
Stevens ME, McConnell M, Bone JM (1982) Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis. Proc Eur Dial Transplant Assoc 19:724–731
Hind CRK, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ (1983) Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet I:263–265
Burran WP, Avasthi P, Smith KJ, Simon TL (1986) Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. Transfusion 26:382–387
Walker RG, d'Apice AJF, Becker GJ, Kincaid-Smith P (1986) Plasma exchange in the treatment of glomerulonephritis and other renal diseases. Aust NZ J Med 16:828–838
Lai KN, Lai FMcM, Leung ACT, Ho CP, Vallance-Owen J (1987) Plasma exchange in patients with rapidly progressive idiopathic IgA nephropathy: a report of two cases and review of the literature. Am J Kidney Dis 10:66–70
Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S (1980) Infectiouns complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244:2423–2426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haycock, G.B. The treatment of glomerulonephritis in children. Pediatr Nephrol 2, 247–255 (1988). https://doi.org/10.1007/BF00862601
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00862601